Related Experiment Video
Updated: Jul 3, 2026
08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
SAR by oxime-containing peptide libraries: application to Tsg101 ligand optimization.
Fa Liu1, Andrew G Stephen, Abdul A Waheed
1Laboratory of Medicinal Chemistry, CCR, NCI-Frederick, Building 376 Boyles Street, Frederick, MD 21702, USA.
Chembiochem : a European Journal of Chemical Biology
|July 26, 2008
Summary
Researchers developed novel peptide inhibitors targeting HIV-1 assembly by disrupting the Gag-p6 PTAP motif interaction with Tsg101. This approach significantly enhanced binding affinity, offering a new strategy for antiviral drug development.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- HIV-1 replication relies on the Gag-p6 protein's PTAP motif for interaction with the host cell factor Tsg101, crucial for viral assembly.
- This interaction is a key target for developing antiviral therapies to inhibit HIV-1 propagation.
Purpose of the Study:
- To design and synthesize novel peptide-based inhibitors that competitively block the PTAP-Tsg101 interaction.
- To optimize inhibitor binding affinity through structure-activity relationship (SAR) studies.
Main Methods:
- Utilized post solid-phase oxime formation for peptide modification.
- Sequentially inserted aminooxy-containing residues into a nonamer peptide scaffold.
- Reacted modified peptides with diverse aldehyde libraries to generate inhibitor candidates.
Main Results:
- Achieved a significant 15-20 fold enhancement in binding affinity for the developed inhibitors.
- Demonstrated the efficacy of the oxime formation strategy in creating potent inhibitors.
Conclusions:
- The developed peptide inhibitors effectively target the critical HIV-1 Gag-p6 PTAP-Tsg101 interaction.
- This methodology provides a promising avenue for the development of new anti-HIV-1 therapeutics.
